Efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in advanced esophagogastric cancers in a phase 1/2 trial.
- Resource Type
- Article
- Authors
- Pinato, David James; Jones, Robert Hugh; Forster, Martin D.; Joshua, Anthony M.; Korolewicz, James; Benafif, Sarah; Aboud, Karam; Liu, Jia; Cosman, Rasha; Paull, Jeremy; Fairley, Jacinth; Edmondson, Stephanie Ruth; Spicer, James F.
- Source
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p374-374, 185p
- Subject
- Language
- ISSN
- 0732183X